Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy

Kidney International

Volumn 50, Issue 5, 1996, Pages 1651-1658

  Breyer, Julia A ^b   Bain, Raymond P ^b   Evans, Joni K ^b   Nahman Jr , N Stanley ^b   Lewis, Edmund J ^b   Cooper, Melisa ^b   Mcgill, Janet ^b   Berl, Tomas ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

EID: 19244364808     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.481     Document Type: Article

References (44)

1. HEALTH CARE FINANCING ADMINISTRATION: ESRD Program Management and Medical Information System. March Update. Baltimore, HCFA, 1990
2. USRDS incidence, causes of treated ESRD. Am J Kidney Dis 24:S48-S56, 1994
3. ANDERSEN AR, CHRISTIANSEN JS, ANDERSEN JK, KREINER S, DECKERT T: Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study. Diabetologia 25:496-501, 1983
4. JONES RH, MACKAY JD, HAYAKAWA H, PARSONS V, WATKINS PJ: Progression of diabetic nephropathy. Lancet 1:1105-1106, 1979
5. MOGENSEN CE, CHRISTENSEN CK: Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89-93, 1984
6. MOGENSEN CE: Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 31:673-689, 1987
7. TIERNEY WM, MCDONALD CJ, LUFT FC: Renal disease in hypertensive adults: Effect of race and type II diabetes mellitus. Am J Kidney Dis 13:485-493, 1989
8. FELDMAN HI, KLAG MJ, CHIAPELLA AP, WHELTON PK: End-stage renal disease in US minority groups. Am J Kidney Dis 19:397-410, 1992
9. MULEC H, JOHNSEN SA, WIKLUND O, BJORCK S: Cholesterol: A renal risk factor in diabetic nephropathy? Am J Kidney Dis 22:196-201, 1993
10. KLEIN R, KLEIN BEK, MOSS SE: The incidence of gross proteinuria in people with insulin-dependent diabetes mellitus. Arch Intern Med 151:1344-1348, 1991
11. MOGENSEN CE: Long-term antihypertensive treatment in inhibiting progression of diabetic nephropathy. Br Med J 185:685-688, 1982
12. PARVING H-H, ANDERSEN AR, SMIDT UM, SVENDSEN PA: Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet i:1175-1178, 1983
13. WALKER WG, HERMANN J, YIN DP, MURPHY RP, PATZ A: Diuretics accelerate diabetic nephropathy in hypertensive insulin-dependent and non-insulin-dependent subjects. Trans Assoc Am Phys 100:305-315, 1987
14. VIBERTI GC, BILOUS RW, MACKINTOSH D, BENDING JJ, KEEN H: Long term correction of hyperglycemia and progression of renal failure in insulin dependent diabetes. Br Med J 286:598-602, 1983
15. WALKER WG, HERMANN J, MURPHY R, PATZ A: Elevated BP and angiotensin II are associated with accelerated loss of renal function in diabetic nephropathy. Trans Am Clin Climatol Assoc 97:94-104, 1985
16. LEWIS EJ, HUNSICKER LG, BAIN RP, ROHDE RD, FOR THE COLLABORATIVE STUDY GROUP: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
17. Sas Language Reference, Version 6. Cary, SAS Institute Inc., 1990
18. COX DR: The Analysis of Binary Data. London, Methuen, 1970
19. LEHMANN EL, D'ABRERA HJM: Nonparametric: Statistical Methods Based on Ranks. San Francisco, Holden-Day, 1975
20. KALBFLEISCH JD, PRENTICE RL: The Statistical Analysis of Failure Time Data. New York, John Wiley, 1980
21. KOSTRABA JN, DORMAN JS, ORCHARD TJ, BECKER DJ, OHKI Y, ELLIS D, DOFT BH, LOBES LA, LAPORTE RE, DRASH AL: Contribution of diabetes duration before puberty to development of microvascular complications in IDDM subjects. Diabetes Care 12:686-693, 1989
22. GABOW PA, JOHNSON AM, KAEHNY WD, KIMBERLING WJ, LEZOTTE DC, DULEY IT, JONES RH: Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int 41:1311-1319, 1992
23. D'AMICO G, MINETTI L, PONTICELLI C, FELLIN G, FERRARIO F, DI BELGIOIOSO GE, IMBASCIATI E, RAGNI A, BERTOLI S, FOGAZZI G, DUCA G: Prognostic indicators in idiopathic IgA mesangial nephropathy. Q J Med 59:363-378, 1986
24. HOPPER J JR, TREW PA, BIAVA CG: Membranous nephropathy: Its relative benignity in women. Nephron 29:18-24, 1981
25. COGGINS CH, BREYER JA, CAGGIULA AW, CASTALDO LS, KLAHR S, WANG SR: Women and men in the MDRD study: A gender analysis of participation in the study protocol and of renal outcomes. Modification of diet in renal disease (MDRD) study group. (manuscript submitted for publication)
26. KANNEL WB: Metabolic risk factors for coronary heart disease in women: Perspective from the Framingham Study. Am Heart J 114: 413-419, 1987
27. WALKER WG: Hypertension-related renal injury: A major contributor to end-stage renal disease. Am J Kidney Dis 22:164-173, 1993
28. WALKER WG, HERMANN J, MURPHY RP, RUSSELL RP: Prospective study of the impact of hypertension upon kidney function in diabetes mellitus. Nephron 55(Suppl 1):21-26, 1990
29. PARVING H-H, ANDERSON AR, SMIDT UM, HOMMEL E, MATHIESEN ER, SVENDSEN PA: Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J 294:1443-1447, 1987
30. BJORCK S, NYBERG G, MULEC H, GRANERUS G, HERLITZ H, AURELL M: Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J 293:471-474, 1986
31. PETERSON JC, ADLER S, BURKART J, GREEN T, HEBERT LA, HUNSICKER LG, KING AJ, KLAHR S, MASSRY SG, SEIFTER JL: Blood pressure control, proteinuria and the progression of renal disease. Ann Intern Med 123:754-762, 1995
32. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure, JNCV. Bethesda, National Institutes of Health, October 30, 1992
33. KAMMEL WB, WOLF PA, VERTER J, MCNAMARA PM: Epidemiologic assessment of the role of blood pressure in stroke (The Framingham Study). JAMA 214:301-310, 1970
34. APPERIOO AJ, DE ZEEUW D, DE JONG PE: Short-term antiproteinuric response to antihypertensive treatment predicts long-term GFR decline in patients with non-diabetic renal disease. Kidney Int 45(Suppl 45:S174-S178, 1994
35. REMUZZI G, BERTANI T: Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? (Editorial Review) Kidney Int 38:384-394, 1990
36. KASISKE BL, O'DONNELL MP, SCHMITZ PG, KIM Y, KEANE WF: Renal injury of diet-induced hypercholesterolemia in rats. Kidney Int 37:880-891, 1990
37. DIAMOND JR, KARNOVSKY MJ: A putative role of hypercholesterolemia in progressive glomerular injury. Ann Rev Med 43:83-92, 1992
38. HARRIS KPG, PURKERSON ML, YATES J, KLAHR S: Lovastatin ameliorates the development of glomerulosclerosis and uremia in experimental nephrotic syndrome. Am J Kidney Dis XV:16-23, 1990
39. SCHARSCHMIDT LA, GIBBONS NA, MCGARRY L, BERGER P, AXELROD M, JANIS R, KO YH: Effects of dietary fish oil on renal insufficiency in rats with subtotal nephrectomy. Kidney Int 32:700-709, 1987
40. ENGERMAN R, BLOODWORTH JM JR, NELSON S: Relationship of microvascular disease in diabetes to metabolic control. Diabetes 26:760-769, 1977
41. COHEN AJ, MCGILL PD, ROSSETTI RG, GUBERSKI DL, LIKE A: Glomerulopathy in spontaneously diabetic rat: Impact of glycemic control. Diabetes 36:944-951, 1987
42. KLEIN R, KLEIN BE, MOSS SE, DAVIS MD, DEMETS DL: The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102:520-526, 1984
43. THE DIABETES CONTROL, COMPLICATIONS TRIAL RESEARCH GROUP: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
44. LEVEY AS, LAU SP, CORWIN HD, KASINATH BS, THE LUPUS NEPHRITIS COLLABORATIVE GROUP: Progression and remission of renal disease in the LNCS: Results of treatment with prednisone and short term oral cyclophosphamide. Ann Intern Med 116:114-123, 1992